Galaxy Biotech LLC is categorized under Commercial Biotechnical Research in Cupertino, CA and active since 2004.
Galaxy Biotech LLC was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Cary Queen at the company’s single location by writing to 22830 San Juan Road, Cupertino, California CA 95014 or by phoning (408) 446-2691. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Galaxy Biotech LLC |
| Contact Person: | Cary Queen |
| Address: | 22830 San Juan Road, Cupertino, California 95014 |
| Phone Number: | (408) 446-2691 |
| Website Address: | galaxybiotech.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Galaxy Biotech LLC was started in 2004 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Cary Queen for inquiries that concern Galaxy Biotech LLC by calling the company number (408) 446-2691, as your correspondence is most welcome. Additionally, the physical location of the single location of Galaxy Biotech LLC can be found at the coordinates 37.313228,-122.074222 as well as the street address 22830 San Juan Road in Cupertino, California 95014.
For its online presence, you may visit Galaxy Biotech LLC’s website at galaxybiotech.com and engage with its social media outlets through on Twitter and on Facebook.